The Estrogen Receptor Joins Other Cancer Biomarkers as a Predictor of Outcome

The Estrogen Receptor Joins Other Cancer Biomarkers as a Predictor of Outcome

Endometrial cancer, the most common gynecologic malignancy in the United States, is on the rise, and survival is worse today than 40 years ago. In order to improve the outcomes, better biomarkers that direct the choice of therapy are urgently needed. In this review, we explore the estrogen receptor...

Full description

Saved in:
Bibliographic Details
Main Authors: Kimberly K. Leslie, Kristina W. Thiel, Henry D. Reyes, Shujie Yang, Yuping Zhang, Matthew J. Carlson, Nirmala S. Kumar, Donghai D. Dai
Format: Article
Language:English
Published: Wiley 2013-01-01
Series:Obstetrics and Gynecology International
Online Access:http://dx.doi.org/10.1155/2013/479541
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items